New Search

If you are not happy with the results below please do another search

1121 search results for:

72

Azenta’s new coloured PCR plates improve visual identification in multi-user labs

Azenta Life Sciences popular FrameStar 96-well Skirted PCR plate is now available in a wide range of colours (purple, blue, clear, green, red, black, and white) to enable easy visual identification in multi-user labs. Whether you work in a busy pathology, molecular diagnostics, or academic lab, assigning different coloured PCR plates can be a real […]

73

PrecisionLife project awarded Innovate UK Grant to improve diagnosis and treatment of ME/CFS and long Covid

Leading computational biology company PrecisionLife, which is driving precision medicine in complex chronic diseases, the ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) charity Action for M.E., and the MRC Human Genetics Unit at the Institute of Genetics and Cancer, University of Edinburgh, have been awarded a £622,000 (about US$794,000) grant by Innovate UK’s Advancing Precision Medicine programme […]

74

ANTABIO raises €25 million for phase 2 next-gen antibacterial study

Antabio SAS, a clinical stage biopharmaceutical company developing novel treatments for severe drug-resistant bacterial infections, has raised €25 million in a Series B financing round, which will enable the company to complete the phase 2 clinical studies of MEM-ANT3310, a next generation antibacterial.

75

Metrion Biosciences closes £3.5m new equity financing to expand Cambridge laboratories

Metrion Biosciences, a specialist ion channel CRO and drug discovery company, has secured £3.5 million (about US$3,19 million) in new equity financing, including £2.5m from lead investor Maven Capital Partners and £1 million from existing investor, Gresham House Ventures. The funding will be used to further expand Metrion’s laboratories in Cambridge, UK, invest in specialist […]

77

ProBioGen granted patent for DirectedLuck transposase technology

ProBioGen’s Transposase binds to specific epigenetic histone marks characteristic for highly active genome regions. Omitting the plasmid backbone, multiple transposable elements carrying the transgene cassette are specifically inserted resulting in highly stable and high expressing clones.

79

Bayer and Broad Institute extend cancer therapy research collaboration

Bayer and the Broad Institute of MIT and Harvard have renewed their research alliance, adding five years to a 10-year collaboration that has already yielded three clinical oncology candidates. This research collaboration is aimed at identifying cancer targets and exploring novel therapeutic approaches in oncology with the goal of bringing more medicines to patients.

80

Azenta selects Oxford for new genomic services facility

Azenta Life Sciences has selected Oxford, UK, a key European life sciences hub, as the location for its next GENEWIZ Multiomics and Synthesis Solutions site. The site will feature a new state-of-the-art genomics lab scheduled to begin full operations in March this year.